The technical configuration is positive
Strategy published on 12/06/2017 | 14:53
Entry price :
227.89$ | Target : 267$ | Stop-loss : 207.5$ | Potential : 17.16%
Align Technology's shares display attractive technical aspects to anticipate a comeback of the underlying trend. Investors have an opportunity to buy the stock and target the $ 267.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The prospective high growth for the next fiscal years is among the main assets of the company Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits. Thanks to a sound financial situation, the firm has significant leeway for investment. Historically, the company has been releasing figures that are above expectations. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. Over the past year, analysts have regularly revised upwards their sales forecast for the company. For the past twelve months, EPS forecast has been revised upwards. For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year. Analysts covering this company mostly recommend stock overweighting or purchase. The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock. The tendency within the weekly time frame is positive above the technical support level at 153.5 USD
Stock prices approach a strong long-term resistance in weekly data at USD 254.76. The company's "enterprise value to sales" ratio is among the highest in the world. With an expected P/E ratio at 62.29 and 52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Subsector Medical Equipment, Supplies & Distribution - NEC
1st jan. Capitalisation (M$) Investor Rating
ALIGN TECHNOLOGY 151.10% 18 892
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.
1 448 M
Net income 2017
P/E ratio 2017
P/E ratio 2018
EV / Sales 2017
EV / Sales 2018
18 892 M
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Short Term Timing
Middle Term Timing
Long Term Timing
Period : Day
Period : Week